CARGO Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 32.08 million compared to USD 13.75 million a year ago. Basic loss per share from continuing operations was USD 1.49 compared to USD 25.62 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.04 USD | +1.96% | -8.75% | -17.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.78% | 748M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- CRGX Stock
- News CARGO Therapeutics, Inc.
- CARGO Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023